目的:研究丁酸钠、曲古抑菌素A(trichostatin A,TSA)及腺病毒E1A相关的300 kD蛋白(adenoviral E1A binding protein of 300 kD,P300)介导的组蛋白乙酰化在人非小细胞肺癌A549细胞及人支气管上皮BEAS-2B细胞中对哮喘易感的解整合素金属...目的:研究丁酸钠、曲古抑菌素A(trichostatin A,TSA)及腺病毒E1A相关的300 kD蛋白(adenoviral E1A binding protein of 300 kD,P300)介导的组蛋白乙酰化在人非小细胞肺癌A549细胞及人支气管上皮BEAS-2B细胞中对哮喘易感的解整合素金属蛋白酶33(a disintegrin and metalloproteinase 33,ADAM33)基因表达的影响。方法:将A549细胞及BEAS-2B细胞分别分为丁酸钠对照组(双蒸水处理)和1、2.5、5 mmol/L丁酸钠组,TSA对照组(0.1%二甲基亚砜处理)和0.2、0.4、0.8μmol/L TSA组,按照组别分别予以相应处理;另将BEAS-2B细胞分为对照组(转染P300突变质粒)和P300组(转染P300表达质粒);采用双荧光素酶报告基因法分析ADAM33启动子活性的变化,实时荧光定量PCR(quantitative real time-PCR,qRT-PCR)检测ADAM33 mRNA表达,蛋白质印迹法检测ADAM33蛋白表达。结果:在人非小细胞肺癌A549细胞中,与对照组相比,1 mmol/L丁酸钠组及0.2μmol/L TSA组ADAM33基因启动子活性明显降低(P<0.01);在BEAS-2B细胞中,与对照组相比,1 mmol/L丁酸钠组及0.2μmol/L TSA组ADAM33基因启动子活性、mRNA及蛋白相对表达水平明显降低(P<0.05或P<0.01)。加大丁酸钠、TSA药物浓度,ADAM33表达无显著差异。在人支气管上皮BEAS-2B细胞中,与对照组相比,P300组ADAM33启动子活性、mRNA和蛋白相对表达水平明显降低(P<0.05)。结论:丁酸钠、TSA通过组蛋白乙酰化降低人非小细胞肺癌A549细胞和人支气管上皮BEAS-2B细胞中ADAM33表达,P300通过组蛋白乙酰化降低人支气管上皮BEAS-2B细胞中ADAM33表达。展开更多
Clear cell renal cell carcinoma(KIRC)is the most common and aggressivemalignancy subtype of renal neoplasm that arises from proximal convoluted tubules.It is characterized by poor clinical outcomes and high mortality ...Clear cell renal cell carcinoma(KIRC)is the most common and aggressivemalignancy subtype of renal neoplasm that arises from proximal convoluted tubules.It is characterized by poor clinical outcomes and high mortality of patients due to the lack of specific biomarkers for varying stages of the disease and no effective treatment.Proteases are associated with the development of several malignant tumors in humans by their ability to degrade extracellular matrices,facilitating metastasis.Herein,differentially expressed genes in KIRC cases compared to healthy kidneys were screened out from the Gene Expression Profiling Interactive Analysis(GEPIA)database.This data was applied to determine the most elevated protease in KIRC and as a result,A Disintegrin and Metalloproteinase Domain-Like Protein Decysin-1(ADAMDEC1)was selected.This expression pattern was exclusive for KIRC and not observed for papillary and chromophobe renal cell carcinomas,in which ADAMDEC1 was at the same level in tumors and non-cancer specimens.Furthermore,the ADAMDEC1 significant increase was detected in the fourteen other human malignancies compared to healthy samples,which suggested its strong involvement in cancer development.Next,GEPIA and Pathology Atlas correlated ADAMDEC1 high expression with more advanced tumor grade and shorter survival of KIRC patients.Xena Functional Genomics Explorer presented that ADAMDEC1 could be hypermethylated in some tumor cases and one somatic mutation in the gene sequence was detected.Finally,a Search Tool for the Retrieval of Interacting Genes/Proteins;STRING base was utilized to predict the interactions of ADAMDEC1 with other molecules and construct the signaling network.In summary,ADAMDEC1 showed the tremendous potential to be the predictive marker for the KIRC and its development.Therefore,this review with data analysis can be a good base for further in vitro and in vivo research that experimentally can confirm the ADAMDEC1 as prognostic biomarkers and therapeutic target of KIRC.展开更多
文摘Clear cell renal cell carcinoma(KIRC)is the most common and aggressivemalignancy subtype of renal neoplasm that arises from proximal convoluted tubules.It is characterized by poor clinical outcomes and high mortality of patients due to the lack of specific biomarkers for varying stages of the disease and no effective treatment.Proteases are associated with the development of several malignant tumors in humans by their ability to degrade extracellular matrices,facilitating metastasis.Herein,differentially expressed genes in KIRC cases compared to healthy kidneys were screened out from the Gene Expression Profiling Interactive Analysis(GEPIA)database.This data was applied to determine the most elevated protease in KIRC and as a result,A Disintegrin and Metalloproteinase Domain-Like Protein Decysin-1(ADAMDEC1)was selected.This expression pattern was exclusive for KIRC and not observed for papillary and chromophobe renal cell carcinomas,in which ADAMDEC1 was at the same level in tumors and non-cancer specimens.Furthermore,the ADAMDEC1 significant increase was detected in the fourteen other human malignancies compared to healthy samples,which suggested its strong involvement in cancer development.Next,GEPIA and Pathology Atlas correlated ADAMDEC1 high expression with more advanced tumor grade and shorter survival of KIRC patients.Xena Functional Genomics Explorer presented that ADAMDEC1 could be hypermethylated in some tumor cases and one somatic mutation in the gene sequence was detected.Finally,a Search Tool for the Retrieval of Interacting Genes/Proteins;STRING base was utilized to predict the interactions of ADAMDEC1 with other molecules and construct the signaling network.In summary,ADAMDEC1 showed the tremendous potential to be the predictive marker for the KIRC and its development.Therefore,this review with data analysis can be a good base for further in vitro and in vivo research that experimentally can confirm the ADAMDEC1 as prognostic biomarkers and therapeutic target of KIRC.